Infantile haemangiomas (IHs) are relatively common benign vascular tumours found in the
paediatric population. They have varying sizes and involve different depths in the skin …

Background Infantile hemangioma (IH) is the most common benign tumor in children with
prevalence in the face and neck. Various treatment options including oral propranolol have …

Infantile hemangiomas (IHs) are the most common tumors of infancy and are usually
characterized by a pattern of rapid proliferation, followed by a slower period of involution. In …

Infantile hemangiomas (IH) are frequent (4–5% of the childhood population) benign vascular
tumors that involve accumulation, proliferation, and differentiation of aberrant vascular cells …

Introdução Os hemangiomas são a lesão tumoral cutânea mais frequente em idade
pediátrica. Até ao momento todas as opções terapêuticas (tanto médicas como cirúrgicas) …

Background: Circular RNAs (circRNAs) have emerged as a novel class of widespread non-
coding RNAs, and they play crucial roles in various biological processes. However, the …

I nfantile hemangiomas (IH s) are proliferating embrional tumors which can stem from
placented tissue and are constituted by endothelial cell hyperproliferation. The management …

CONCLUSION: Propranolol is effective in the treatment of IH and it has only few and mild
side effects. In most cases, a low dose of 1 mg/kg/day was sufficient. Early initiation of …

Accurate and objective measurement of volume changes in infantile hemangiomas (IHs) is
essential in routine clinical practice and clinical studies, particularly in the changing …

Background Propranolol is a first-line clinical drug for infantile haemangiomas (IH) therapy.
Nevertheless, resistance to propranolol is observed in some patients with IH. Circular RNAs …